Received Feb 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
breakout of red dots around her mouth/ looking like fever blisters before they blistered; This non-serious case was reported by a consumer via call center representative and described the occurrence of red spotty rash in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced red spotty rash (Verbatim: breakout of red dots around her mouth/ looking like fever blisters before they blistered). The outcome of the red spotty rash was unknown. It was unknown if the reporter considered the red spotty rash to be related to Shingrix. It was unknown if the company considered the red spotty rash to be related to Shingrix. Additional Information: GSK Receipt Date: 08-JAN-2025 Reporter was the patient who received her first dose of Shingrix a little over a week ago (from the date of reporting). She stated that the day after the vaccination, she experienced a breakout of red dots around her mouth. She described it as looking like fever blisters before they blistered.